(Q43948995)
Statements
Hemophilia therapy innovation: development of an advanced category recombinant factor VIII by a plasma/albumin-free method. Proceedings of a Special Symposium at the XIXth Congress of the International Society on Thrombosis and Haemostasis, July 12-18, 2003, Birmingham, UK (English)
B M Ewenstein
V Blanchette
E D Gomperts
P Collins
M D Tarantino
A D Shapiro
D Baker
G Spotts
M Sensel
1-16; discussion 16-8